Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company announcement – No. 24 / 2019 Zealand Pharma announces change in corporate management Copenhagen, Denmark, July 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50...
-
Company announcement – No. 23 / 2019 Total number of shares and voting rights in Zealand Pharma at June 30, 2019 Copenhagen, June 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no....
-
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome,...
-
Company announcement – No. 22 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, June 14, 2019 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 21 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, June 13, 2019 – Zealand Pharma A/S...
-
Company announcement – No. 20 / 2019 Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program Copenhagen, June 13, 2019 – Zealand...
-
Press release – No. 13 / 2019 Zealand Pharma to attend Citi European Healthcare Conference Copenhagen, June 4, 2019 – Zealand Pharma Chief Executive Officer Emmanuel Dulac and Chief Medical and...
-
Company announcement – No. 18 / 2019 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 Copenhagen, June 3, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...